Browsing Tag
Danaher
2 posts
Qiagen (NYSE: QGEN) at a crossroads ahead of new CEO and Q1 2026 results
Qiagen (NYSE: QGEN) retail investor roadmap: strategic review, CEO search, 2026 product pipeline and what the May earnings call means for shareholders.
April 3, 2026
Danaher to acquire protein consumables supplier Abcam for $5.7bn
Danaher Corporation (NYSE: DHR), a global science and technology innovator, has announced a definitive agreement to acquire Abcam…
August 28, 2023